Generic Name and Formulations:
Genistein (as aglycone) 27mg, citrated zinc (as bisglycinate) 20mg, cholecalciferol (Vit.D3) 200IU; caps; lactose-, gluten-free; contains soy.
Indications for FOSTEUM:
Dietary management of osteopenia and osteoporosis.
1 cap twice daily; supplement with calcium and Vit.D3 as needed.
History of breast or reproductive organ cancer. Pregnancy. Nursing mothers.
Not for treatment of Vit.D deficiency. Women who have 1st degree female relative with history of breast or reproductive cancer. Women capable of becoming pregnant (use adequate contraception). Males: not recommended. Severe hepatic or renal impairment. Conditions associated with overproduction of calcitriol (eg, leukemia, lymphoma, sarcoidosis) or signs/symptoms of Vit.D toxicity; monitor urine and serum calcium. Long-term supplementation or high-doses of zinc-containing products: monitor zinc and copper levels. GI malabsorption; may need higher Vit.D3 doses (monitor). Ensure adequate calcium and Vit.D3 intake.
Concomitant HRT, SERMs: not recommended. Vit.D3 absorption may be decreased by bile acid sequestrants, mineral oil, orlistat, olestra. Cimetidine, thiazides, anticonvulsants may increase Vit.D3 catabolism.
Abdominal and epigastric pain, dyspepsia, vomiting, constipation.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Minority Residents Experience Burdens Linked to Race/Ethnicity
- Tips Provided for Budgeting in Medical Residency
- Oxidized Low-Density Lipoprotein May Predict Risk for Recurrent Stroke
- Inappropriate Prescribing Protocols in Parkinson Disease
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis